Read Dr. Hebah Qashqari’s Early Career Blog
Read the latest early career blog post, from NMD4C member Dr. Hebah Qashqari.
Dr. Qashqari completed her Bachelor in Medicine and Surgery followed by her Pediatric residency at King Abdul-Aziz University, Saudi Arabia. Following this, she successfully completed her Pediatric Neurology Residency Training at The Hospital for Sick Children and got certified as a Fellow by The Royal College of Physicians and Surgeons of Canada (FRCPC). After that, she finished her Pediatric Neuromuscular Fellowship (2019-2020) at The Hospital for Sick Children, Toronto, Canada.
Read next...
Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
2026 Awards Now Open for Nominations!
We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.